Sanctuary Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$518 Hold
22
﹤0.01% 261
2024
Q3
$563 Hold
22
﹤0.01% 261
2024
Q2
$517 Sell
22
-70
-76% -$1.77K ﹤0.01% 246
2024
Q1
$2.65K Sell
92
-206
-69% -$6.2K ﹤0.01% 193
2023
Q4
$9.78K Sell
298
-53
-15% -$1.44K 0.01% 151
2023
Q3
$9.78K Sell
351
-172
-33% -$5.62K 0.01% 135
2023
Q2
$17.8K Buy
+523
New +$16.4K 0.02% 120
2022
Q4
$15.6K Buy
+553
New +$17.6K 0.02% 112
2021
Q3
Sell
-2,391
Closed -$221K 31
2021
Q2
$221K Buy
+2,391
New +$203K 0.27% 33

Other funds holding ARKG

Sanctuary Wealth Management's ARKG Position: Q4 2024 in Review

Sanctuary Wealth Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q4 2024 at 22 shares worth $518. The position accounts for ﹤0.01% of the portfolio, ranked #261.

Sanctuary Wealth Management first reported a position in ARKG in Q2 2021 and has held it in 9 quarters since. The position peaked at $221K in Q2 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • Sanctuary Wealth Management held 22 shares of ARK Genomic Revolution ETF worth $518 as of Q4 2024.
  • Sanctuary Wealth Management left its ARK Genomic Revolution ETF share count unchanged in Q4 2024.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Sanctuary Wealth Management's portfolio in Q4 2024, its #261 holding.
  • Sanctuary Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2021 and has held it in 9 quarters since.
  • Sanctuary Wealth Management's ARK Genomic Revolution ETF position peaked at $221K in Q2 2021.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Sanctuary Wealth Management's 13F filing for Q4 2024, filed 12 Feb 2025.